A detailed history of Daiwa Securities Group Inc. transactions in Uni Qure N.V. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 158 shares of QURE stock, worth $913. This represents 0.0% of its overall portfolio holdings.

Number of Shares
158
Previous 158 -0.0%
Holding current value
$913
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021

BUY
$26.01 - $38.22 $1,924 - $2,828
74 Added 88.1%
158 $5,000
Q4 2020

Feb 04, 2021

SELL
$35.35 - $50.67 $5,726 - $8,208
-162 Reduced 65.85%
84 $3,000
Q4 2019

Jan 31, 2020

BUY
$37.13 - $74.62 $259 - $522
7 Added 2.93%
246 $17,000
Q1 2019

Apr 26, 2019

BUY
$27.39 - $68.41 $6,546 - $16,349
239 New
239 $14,000
Q4 2018

Feb 05, 2019

SELL
$22.8 - $33.93 $3,876 - $5,768
-170 Closed
0 $0
Q1 2018

May 02, 2018

BUY
$17.1 - $26.61 $2,907 - $4,523
170 New
170 $4,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $270M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.